Answers are grounded in this paper and cite their sources.
The AI-based clinical trial matching system allows efficient and reliable screening of cancer patients for clinical trials with 95.7% accuracy for exclusion and 91.6% accuracy for overall eligibility assessment; however, clinician input and oversight are still required. The automated system demonstrates promise as a clinical decision support tool to prescreen a large patient cohort to identify subjects suitable for further assessment.
No takes yet. Share an insight, caveat, or question.
Alexander et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: